Table 1
Clinical and demographic data of multiple sclerosis (MS) patients and healthy control subjects
| Demographics | Relapsing-remitting MS | Secondary progressive MS | All MS | Controls |
| Subjects, no | 17 | 3 | 20 | 20 |
| Mean age, years (SD) | 40.3 (13.9) | 55.3 (9.3) | 42.2 (13.3) | 34.3 (11.0) |
| Sex male/female | 5/12 | 2/1 | 7/13 | 10/10 |
| Extended Disability Status Scale range/median/SD | 0–4.5/3/1.3 | 4–6.5/6/1.3 | 0–6.5/3/1.7 | / |
| Disease duration, years, range/mean/SD | 1–35/11.2/10.2 | 11–36/23/12.5 | 1–36/13.1/11.1 | / |
| Patients on medication, no | 15/17 | 3/3 | 18/20 | / |
| Patients on natalizumab, no/total | 10/15 | 0 | 10/20 | / |
| Relapses*, no, range/mean/SD | 0–4/0.9/1.1 | 0 | 0–4/0.9/1.1 | / |
| CSF positive†, no/total | 16/17 | 3/3 | 19/20 | / |
| MRI positive‡, no/total | 17/17 | 3/3 | 20/20 | / |
